SSEA-1 Antibodies

Santa Cruz Biotechnology offers a broad range of SSEA-1 monoclonal antibodies for advanced research in cell biology and developmental studies. SSEA-1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SSEA-1, or Stage-Specific Embryonic Antigen-1, is a glycosphingolipid that plays a crucial role in cell differentiation and development. SSEA-1 is primarily expressed in embryonic stem cells and certain cancer cells, making it an important marker for stem cell research and cancer studies. Understanding SSEA-1 function provides valuable insights into cellular processes and potential therapeutic applications. Researchers worldwide rely on SSEA-1 monoclonal antibodies to advance their understanding of developmental biology and stem cell characteristics. SSEA-1 monoclonal antibodies enable detailed investigation of cellular differentiation pathways and developmental stages. Santa Cruz Biotechnology monoclonal antibodies for SSEA-1 support researchers in making meaningful contributions to regenerative medicine and cancer research.